Danaos Corp (DAC) shareholders
Close on Nov 13, 2026Market cap $2.74BP/E 5.6Yield 0.57%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Danaos Investment Limited as Trustee of the 883 Trust Joint filing with John Coustas (51.80%) | 9,538,502 | 51.80% | 13D (active) amendment | Nov 14, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DAC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 692,176 | 3.79% | $84.66M | −838 | 0.10% |
| RBF Capital, LLC | 418,015 | 2.29% | $51.15M | – | 2.12% |
| ION Fund Management Ltd | 410,977 | 2.25% | $50.29M | +29,855 | 3.19% |
| BlackRock, Inc. | 319,132 | 1.75% | $39.05M | +229,570 | 0.00% |
| No Street GP LP | 250,000 | 1.37% | $30.59M | – | 1.84% |
| Goldman Sachs Group Inc | 223,665 | 1.22% | $27.37M | −73,571 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 153,710 | 0.84% | $18.81M | +76,820 | 0.01% |
| JPMorgan Chase & Co | 121,616 | 0.67% | $14.93M | +3,255 | 0.00% |
| Qube Research & Technologies Ltd | 100,352 | 0.55% | $12.28M | +32,561 | 0.01% |
| Morgan Stanley | 72,077 | 0.39% | $8.82M | +853 | 0.00% |
| Two Sigma Investments, LP | 64,716 | 0.35% | $7.92M | −32,111 | 0.01% |
| Hi-Line Capital Management, LLC | 61,467 | 0.34% | $7.52M | +1,219 | 2.12% |
| Raymond James Financial Inc | 60,946 | 0.33% | $7.46M | +1,740 | 0.00% |
| Russell Investments Group, Ltd. | 50,276 | 0.28% | $6.17M | +59 | 0.01% |
| Advisory Research Inc | 47,412 | 0.26% | $5.80M | +5 | 0.58% |
| Sei Investments Co | 46,741 | 0.26% | $5.72M | +2,493 | 0.01% |
| Bnp Paribas Arbitrage, Snc | 46,238 | 0.25% | $5.66M | +11,582 | 0.00% |
| Hrt Financial LP | 43,936 | 0.24% | $5.38M | +3,507 | 0.00% |
| PDT Partners, LLC | 42,564 | 0.23% | $5.21M | +13,474 | 0.27% |
| Renaissance Technologies LLC | 35,753 | 0.20% | $4.38M | −48,047 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 136 | 4M | 21.0% | 23 / 48 | 38 / 21 | 1M | 0M |
| Q1 2026 | 137 | 4M | 20.2% | 26 / 47 | 40 / 20 | 1M | 1M |
| Q4 2025 | 133 | 4M | 21.3% | 28 / 43 | 43 / 14 | 1M | 1M |
| Q3 2025 | 123 | 4M | 19.3% | 21 / 51 | 30 / 9 | 1M | 1M |
| Q2 2025 | 111 | 3M | 18.4% | 24 / 32 | 39 / 24 | 0M | 0M |
| Q1 2025 | 112 | 3M | 18.2% | 21 / 32 | 38 / 24 | 0M | 1M |
| Q4 2024 | 117 | 4M | 19.8% | 20 / 43 | 39 / 27 | 1M | 1M |
| Q3 2024 | 124 | 4M | 20.6% | 17 / 44 | 43 / 22 | 0M | 1M |
| Q2 2024 | 131 | 4M | 23.7% | 27 / 49 | 38 / 24 | 1M | 1M |
| Q1 2024 | 128 | 4M | 23.9% | 31 / 42 | 34 / 15 | 1M | 1M |
| Q4 2023 | 113 | 4M | 22.6% | 21 / 45 | 29 / 16 | 1M | 1M |
| Q3 2023 | 108 | 4M | 20.8% | 19 / 42 | 30 / 13 | 1M | 1M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Coustas | Chief Executive Officer, Director | 9,538,502 | 52.22% | Mar 18, 2026 |
| Dimitrios Vastarouchas | VP and Chief Operating Officer | – | – | Mar 18, 2026 |
| Filippos Prokopakis | Chief Commercial Officer | 4,001 | 0.02% | Mar 18, 2026 |
| Evangelos Chatzis | VP, CFO, Treasurer & Secretary | 50,000 | 0.27% | Mar 18, 2026 |
| Petros Christodoulou | Director | – | – | Mar 18, 2026 |
| Myles R. Itkin | Director | 4,000 | 0.02% | Mar 18, 2026 |
| Richard Lindsay Sadler | Director | – | – | Mar 18, 2026 |
| Charalampos Pampoukis | Director | – | – | Mar 18, 2026 |
| Iraklis Prokopakis | Director | 194,693 | 1.07% | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Danaos's stock actually held short. Settlement fails (shares not delivered on time) peaked at 66,547 shares on Oct 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Evangelos Chatzis Officer | Mar 25, 2025 | 7,500 | $606.37K | Mar 25, 2025 | Stock Award under a Registered Equity Plan |
| Evangelos Chatzis Officer | Mar 24, 2025 | 7,500 | $610.47K | Mar 24, 2025 | Stock Award under a Registered Equity Plan |
| Evangelos Chatzis Officer | Mar 21, 2025 | 8,000 | $653.95K | Mar 21, 2025 | Stock Award under a Registered Equity Plan |
| Evangelos Chatzis Officer | Mar 27, 2024 | 5,000 | $362.36K | Mar 27, 2024 | Stock Award |
| Evangelos Chatzis Officer | Mar 7, 2024 | 5,000 | $357.02K | Mar 7, 2024 | Stock Award |
| Evangelos Chatzis Officer | Mar 1, 2024 | 5,000 | $362.47K | Mar 1, 2024 | Stock Award |
| Evangelos Chatzis Officer | Feb 23, 2024 | 5,000 | $366.43K | Feb 23, 2024 | Stock Award |
| Evangelos Chatzis Officer | May 23, 2023 | 5,739 | $345.18K | May 23, 2023 | Stock Award |
| Evangelos Chatzis Officer | May 19, 2023 | 4,261 | $264.13K | May 19, 2023 | Stock Award |
| Evangelos Chatzis Officer | May 17, 2023 | 10,000 | $619.14K | May 17, 2023 | Stock Award |
See a number that looks wrong?